The presence of the factor V Leiden and the prothrombin G20210A polymorphism does not appear to influence the risk of thrombosis in essential thrombocythaernia: results of a nested... by Robinson, S, Campbell, P, Bench, A, Buck, G, Wheatley, K, East, C, Collins, P, Green, A, Harrison, C

Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes. by Wilkins, B, Erber, W, Bareford, D, Buck, G, Wheatley, K, East, C, Paul, B, Harrison, C, Green, A, Campbell, P

The medical research council PT1 trial in essential thrombocythemia. by Green, A, Campbell, P, Buck, G, Wheatley, K, East, C, Bareford, D, Wilkins, B, Van der Walt, J, Reilly, J, Harrison, C

Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. by Harrison, C, Campbell, P, Buck, G, Wheatley, K, East, C, Bareford, D, Wilkins, B, van der Walt, JD, Reilly, J, Grigg, A, Revell, P, Woodcock, B, Green, A

JAK2 V617F mutation identifies a biologically distinct subtype of essential thrombocythemia which resembles polycythemia vera. by Green, A, Campbell, P, Scott, L, Buck, G, Wheatley, K, East, C, Marsden, J, Duffy, A, Boyd, E, Bench, A, Scott, M, Vassiliou, G, Milligan, D, Smith, S, Erber, W, Bareford, D, Wilkins, B, Reilly, J, Harrison, C

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study. by Campbell, P, Scott, L, Buck, G, Wheatley, K, East, C, Marsden, J, Duffy, A, Boyd, E, Bench, A, Scott, M, Vassiliou, G, Milligan, D, Smith, SR, Erber, W, Bareford, D, Wilkins, B, Reilly, J, Harrison, C, Green, A